Recital 8, Regulation (EU) 2022/112

In forcesince 25 Jan 2022

In order to allow in vitro diagnostic medical devices which have been lawfully placed on the market in accordance with the transitional provisions laid down in this Regulation sufficient time to continue to be made available on the market, including to be supplied to end users, or to be put into service, the sell-off date of 27 May 2025 provided for in Regulation (EU) 2017/746 should be adapted to take into account the additional transitional periods provided for in this Regulation.